Promising targeted therapy offers new hope to certain patients with advanced pancreatic cancer
A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the ...
A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the ...
Three clinical trials led by researchers at The University of Texas MD Anderson Cancer Center demonstrated positive results from the ...
A recent clinical trial showed that the drug combination of cemiplimab plus platinum chemotherapy can prolong survival in patients with ...
Researchers at the University of East Anglia have developed a new drug that works against all of the main types ...
In a recent study published in the Journal of Antimicrobial Chemotherapy, researchers developed an antibiotic resistance (ABR) awareness scale to ...
Research conducted by UC Davis Comprehensive Cancer Center and the University of Cincinnati shows that direct oral anti-coagulant (DOAC) drugs ...
Giving standard chemotherapy drugs in a specific sequence for some types of metastatic breast cancer can help reduce overall costs ...
A promising new targeted cancer therapy will soon be available to certain patients with advanced pancreatic cancer – from the...
Read moreNEWS RELEASE: MGS MFG. Group acquires Danish product design firm Technolution Members of Technolution and MGS Mfg. Group GERMANTOWN, Wis....
Read moreIn a recent study published in the Nutrients Journal, researchers explored the phytochemical contents and health benefits of consuming figs....
Read moreDeviceTalks Editorial Director Tom Salemi (left) interviewed Boston Scientific CEO Mike Mahoney (right) in front of a crowd of medtech...
Read more© Medical Writers News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
© 2022 Medical Writers News Hubb All rights reserved.